In chronic pyoderma patients, staged treatment with thymogen, antibiotics and immune stimulators produced up to 73.9% clinical recoveries.
In plain wordsIn chronic pyoderma patients, combined treatment with thymogen produced up to 73.9% clinical recoveries.
- Peptide
- Thymogen (oglufanide)
- Outcome
- Not applicableClinical recovery
- Study
n = 23
- Outcome group
- Infection and antimicrobial activity · Skin and wound
Measurements
- Clinical recovery
- ≤ 73.9%
- complex management of chronic pyoderma
Source sentences
The results prove the high efficiency of thymogen application in complex management of chronic pyoderma: up to 73.9% of clinic recoveries.
2 context sentences(design, population, supporting numbers)
Summarizing the results of treatment in 23 patients the authors propose an effective two-staged method to treat chronic pyoderma.
The second stage of this method consists in administration of antibiotics in combination with stimulators of phagocytosis and humoral immunity.
In this study, Thymogen (oglufanide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymogen (oglufanide).